U.S. FDA Approves Lenacapavir: First Twice-Yearly HIV Prevention Shot
The U.S. Food and Drug Administration (FDA) has given its official approval to Lenacapavir as the first-ever twice-yearly injectable medication for HIV prevention, commonly known as PrEP (pre-exposure prophylaxis). This milestone marks a groundbreaking advancement in HIV prevention strategies, offering a new option for people who